Partial remission of acute myeloid leukemia complicating multiple myeloma following COAP chemotherapy: A case report.

about

Partial remission of acute myeloid leukemia complicating multiple myeloma following COAP chemotherapy: A case report.

Item

http://www.wikidata.org/entity/Q40170328

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Partial remission of acute mye ...... P chemotherapy: A case report.

@en

type

Item

label

Partial remission of acute mye ...... P chemotherapy: A case report.

@en

prefLabel

Partial remission of acute mye ...... P chemotherapy: A case report.

@en

P1476

Partial remission of acute mye ...... P chemotherapy: A case report.

@en

P2093

Jia-Jia Zhang

http://www.w3.org/2001/XMLSchema#string

Man Shen

http://www.w3.org/2001/XMLSchema#string

Na An

http://www.w3.org/2001/XMLSchema#string

Wan-Jun Sun

http://www.w3.org/2001/XMLSchema#string

Xin Li

http://www.w3.org/2001/XMLSchema#string

Zhong-Xia Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance

PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma.

Second solid cancers after radiotherapy for breast cancer in SEER cancer registries.

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients.

Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries

Second malignancies after multiple myeloma: from 1960s to 2010s.

Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence: part II-leukemia and myeloma.

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.

P304

1303-1306

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2015.2867

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272097634

http://www.w3.org/2001/XMLSchema#string

P698

25663902

http://www.w3.org/2001/XMLSchema#string

P932

4315064

http://www.w3.org/2001/XMLSchema#string